Jaguar Health (JAGX) vs Kiora Pharmaceuticals (KPRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Kiora Pharmaceuticals is the larger company by market cap ($3.2 million vs $3.0 million), about 1.1 times the size, while Jaguar Health is growing revenue faster (-1.5% vs -100.0%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | JAGX | KPRX |
|---|---|---|
| Share price | $0.227 | $0.7202 |
| Market cap | $3.03M | $3.19M |
| 1-day change | -30.58% | -12.28% |
| YTD return | — | -63.44% |
| 1-year return | — | -61.49% |
| 5-year return | — | -99.87% |
| EPS (TTM) | $-257.15 | $-2.72 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $11.51M | $0 |
| Revenue growth (YoY) | -1.52% | -100.00% |
| Net income (latest FY) | $-53.58M | $-10.84M |
| Gross margin | 67.21% | — |
| Operating margin | -398.82% | — |
| Net margin | -465.42% | — |
| 52-week high | $981.75 | $2.91 |
| 52-week low | $0.22 | $0.72 |
| Distance from 52-week high | -99.98% | -75.25% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +1566.20% |
| Average volume | 2.40M | 35.23K |
| Shares outstanding | 13.35M | 4.42M |
| Employees | 47 | 13 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Jaguar Health grew revenue faster in its latest fiscal year (-1.52% vs -100.00%).
About Jaguar Health
JAGX stock →Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health.
Health Care · Biotechnology: Pharmaceutical Preparations · 47 employees
About Kiora Pharmaceuticals
KPRX stock →Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 2 clinical trials for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease.
Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees
JAGX vs KPRX FAQ
Which is bigger, Jaguar Health or Kiora Pharmaceuticals?
Kiora Pharmaceuticals (KPRX) is larger, with a market capitalization of $3.19M compared with $3.03M for Jaguar Health (JAGX).
Are Jaguar Health and Kiora Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.